Pharma Insider Sells 4,772 Shares as 2025 Revenue Hits $883M
A high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
Yearly performance of total market index funds provides a broad view of winners and laggards. Use these insights to adjust your exposure today.
28,320 articlesA high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
Public headlines rarely tell the whole story about the economy or your wallet. This article breaks down how political...
TSMC projects rapid AI chip revenue growth through 2029. This article breaks down what that means for investors in 20...
Rivian faces a challenging journey into 2026, with big questions about profitability, demand, and policy shifts. This...
A staggering, six-sigma-type move in tech stocks grabbed headlines. This article breaks down what happened, why it’s ...
As 2026 unfolds, a value-led rotation is drawing fresh money into the Vanguard Value ETF (VTV). With inflation coolin...
Investors are eyeing Cerebras Systems' chips faster claims against Nvidia's Blackwell models. This deep dive explains...
A fresh risk-off wave hits crypto markets as the VIX climbs past 29, pushing ProShares Ultra Ether ETF (ETHT) and Eth...
A popular fallen angel ETF delivers about 6% yield paid monthly by buying bonds downgraded from investment grade. It’...
In a volatile market, a strategically chosen oil major could outperform the S&P 500 in the latter half of 2026. This ...
Investing in SpaceX stock this week requires more than headlines. This guide offers a clear framework, real-world sce...
A mixed quarter and a tougher backdrop pushed KE Holdings shares lower, underscoring how market forces and sector hea...